Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OIN-16008509Phase 3Recruiting
Phase 3, randomised trial of medroxyprogesterone acetate, human menopausal gonadotrophin and gonadotropin-releasing hormone agonist in endometriosis and female infertility (3 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: oocyte retrieval rate, maturation rate and 5 more. Started May 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OIN-16008509.